Phase II clinical trial - Mélanome uvéal et tumeurs oculaires

PLUME
Mélanome uvéal et tumeurs oculaires
Ouvert depuis le: 03.03.2024
Site: Paris
Public cible
Adulte
A phase II, monocentric, single arm trial;evaluating the efficacy and safety of;Pembrolizumab in combination with Lenvatinib;in metastatic Uveal MElanoma patients
Description de l'essai
Phase II, single-centre, single-arm study combining lenvatinib and pembrolizumab in patients with metastatic MU.;Each participant will receive the combination of pembrolizumab (for a maximum of 35 cycles) and lenvatinib until disease progression or significant toxicity.
Vignette
MANUEL RODRIGUES
Investigateur principal